BioPorto Correlations
| BIOPOR Stock | DKK 1.62 0.01 0.61% |
The current 90-days correlation between BioPorto and Zealand Pharma AS is 0.11 (i.e., Average diversification). The correlation of BioPorto is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
BioPorto Correlation With Market
Significant diversification
The correlation between BioPorto and DJI is 0.09 (i.e., Significant diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding BioPorto and DJI in the same portfolio, assuming nothing else is changed.
BioPorto |
The ability to find closely correlated positions to BioPorto could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace BioPorto when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back BioPorto - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling BioPorto to buy it.
Moving together with BioPorto Stock
Related Correlations Analysis
| Click cells to compare fundamentals | Check Volatility | Backtest Portfolio |
Risk-Adjusted Indicators
There is a big difference between BioPorto Stock performing well and BioPorto Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze BioPorto's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.Be your own money manager
Our tools can tell you how much better you can do entering a position in BioPorto without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Portfolio Suggestion Now
Portfolio SuggestionGet suggestions outside of your existing asset allocation including your own model portfolios |
| All Next | Launch Module |
BioPorto Corporate Management
Elected by the shareholders, the BioPorto's board of directors comprises two types of representatives: BioPorto inside directors who are chosen from within the company, and outside directors, selected externally and held independent of BioPorto. The board's role is to monitor BioPorto's management team and ensure that shareholders' interests are well served. BioPorto's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, BioPorto's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Christopher Bird | Chief Officer | Profile | |
| Neil CPA | Ex CFO | Profile | |
| Jennifer Zonderman | VP Commercialization | Profile | |
| Lars Uttenthal | Chief Officer | Profile | |
| Gry Larsen | G Counsel | Profile | |
| Nis Kruse | Ex APAC | Profile | |
| Anthony Pare | Chief Officer | Profile |